Development of Theranostic Cationic Liposomes Designed for Image-Guided Delivery of Nucleic Acid

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2020 Sep 11

PMID 32911863

Citations 7

Authors

Hai Doan Do

Christine Menager

Aude Michel

Johanne Seguin

Tawba Korichi

Helene Dhotel

Corinne Marie

Bich-Thuy Doan

Nathalie Mignet

Affiliations

Soon will be listed here.

Abstract

Cationic liposomes have been considered as potential vectors for gene delivery thanks to their ability to transfect cells with high efficiency. Recently, the combination of diagnostic agent and therapeutic agents in the same particle to form a theranostic system has been reported. Magnetic liposomes are one of these examples. Due to the magnetic nanoparticles encapsulated in the liposomes, they can act as a drug delivery system and, at the same time, a magnetic resonance imaging contrast enhancement agent or hyperthermia. In this work, nucleic acid delivery systems based on magnetic cationic liposomes (MCLs) were developed. Two different techniques, reverse phase evaporation and cosolvent sonication, were employed for liposome preparation. Both strategies produced MCLs of less than 200 nm with highly positive charge. Enhancement of their transverse and longitudinal relaxivities and was obtained with both kinds of magnetic liposomes compared to free magnetic nanoparticles. Moreover, these MCLs showed high capacity to form complexes and transfect CT-26 cells using the antibiotic-free pFAR4-luc plasmid. The transfection enhancement with magnetofection was also carried out in CT26 cells. These results suggested that our MCLs could be a promising candidate for image-guided gene therapy.

Citing Articles

Tissue Nanotransfection Silicon Chip and Related Electroporation-Based Technologies for In Vivo Tissue Reprogramming.

Xuan Y, Wang C, Ghatak S, Sen C Nanomaterials (Basel). 2024; 14(2).

PMID: 38276735 PMC: 10820803. DOI: 10.3390/nano14020217.

Electrospun Magnetic Nanofiber Mats for Magnetic Hyperthermia in Cancer Treatment Applications-Technology, Mechanism, and Materials.

Mamun A, Sabantina L Polymers (Basel). 2023; 15(8).

PMID: 37112049 PMC: 10143376. DOI: 10.3390/polym15081902.

Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery.

Duong V, Nguyen T, Maeng H Pharmaceutics. 2023; 15(1).

PMID: 36678838 PMC: 9865923. DOI: 10.3390/pharmaceutics15010207.

Recent Advance of Liposome Nanoparticles for Nucleic Acid Therapy.

Gao Y, Liu X, Chen N, Yang X, Tang F Pharmaceutics. 2023; 15(1).

PMID: 36678807 PMC: 9864445. DOI: 10.3390/pharmaceutics15010178.

Emerging trends in the nanomedicine applications of functionalized magnetic nanoparticles as novel therapies for acute and chronic diseases.

Dash S, Das T, Patel P, Panda P, Suar M, Verma S J Nanobiotechnology. 2022; 20(1):393.

PMID: 36045375 PMC: 9428876. DOI: 10.1186/s12951-022-01595-3.

References

Bealle G, Di Corato R, Kolosnjaj-Tabi J, Dupuis V, Clement O, Gazeau F . Ultra magnetic liposomes for MR imaging, targeting, and hyperthermia. Langmuir. 2012; 28(32):11834-42. DOI: 10.1021/la3024716. View

Nicolazzi C, Garinot M, Mignet N, Scherman D, Bessodes M . Cationic lipids for transfection. Curr Med Chem. 2003; 10(14):1263-77. DOI: 10.2174/0929867033457467. View

Thebault C, Ramniceanu G, Michel A, Beauvineau C, Girard C, Seguin J . In Vivo Evaluation of Magnetic Targeting in Mice Colon Tumors with Ultra-Magnetic Liposomes Monitored by MRI. Mol Imaging Biol. 2018; 21(2):269-278. DOI: 10.1007/s11307-018-1238-3. View

Li Y, Cui X, Chen Q, Yu J, Zhang H, Gao J . Cationic liposomes induce cytotoxicity in HepG2 via regulation of lipid metabolism based on whole-transcriptome sequencing analysis. BMC Pharmacol Toxicol. 2018; 19(1):43. PMC: 6042442. DOI: 10.1186/s40360-018-0230-5. View

Faraji A, Wipf P . Nanoparticles in cellular drug delivery. Bioorg Med Chem. 2009; 17(8):2950-62. DOI: 10.1016/j.bmc.2009.02.043. View

Zheng X, Lu J, Deng L, Xiong Y, Chen J . Preparation and characterization of magnetic cationic liposome in gene delivery. Int J Pharm. 2008; 366(1-2):211-7. DOI: 10.1016/j.ijpharm.2008.09.019. View

Peng Z, Wang C, Fang E, Lu X, Wang G, Tong Q . Co-delivery of doxorubicin and SATB1 shRNA by thermosensitive magnetic cationic liposomes for gastric cancer therapy. PLoS One. 2014; 9(3):e92924. PMC: 3968034. DOI: 10.1371/journal.pone.0092924. View

Bessodes M, Dhotel H, Mignet N . Lipids for Nucleic Acid Delivery: Cationic or Neutral Lipoplexes, Synthesis, and Particle Formation. Methods Mol Biol. 2019; 1943:123-139. DOI: 10.1007/978-1-4939-9092-4_8. View

Reddy L, Arias J, Nicolas J, Couvreur P . Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev. 2012; 112(11):5818-78. DOI: 10.1021/cr300068p. View

10.

Lv H, Zhang S, Wang B, Cui S, Yan J . Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release. 2006; 114(1):100-9. DOI: 10.1016/j.jconrel.2006.04.014. View

11.

Byk G, Dubertret C, Escriou V, Frederic M, Jaslin G, Rangara R . Synthesis, activity, and structure--activity relationship studies of novel cationic lipids for DNA transfer. J Med Chem. 1998; 41(2):229-35. DOI: 10.1021/jm9704964. View

12.

Mulligan R . The basic science of gene therapy. Science. 1993; 260(5110):926-32. DOI: 10.1126/science.8493530. View

13.

Baraldo K, Leforestier N, Bureau M, Mignet N, Scherman D . Sphingosine-based liposome as DNA vector for intramuscular gene delivery. Pharm Res. 2002; 19(8):1144-9. DOI: 10.1023/a:1019894008885. View

14.

Riley M, Vermerris W . Recent Advances in Nanomaterials for Gene Delivery-A Review. Nanomaterials (Basel). 2017; 7(5). PMC: 5449975. DOI: 10.3390/nano7050094. View

15.

Culver K, Cornetta K, Morgan R, Morecki S, Aebersold P, Kasid A . Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proc Natl Acad Sci U S A. 1991; 88(8):3155-9. PMC: 51404. DOI: 10.1073/pnas.88.8.3155. View

16.

Yuan F, Dellian M, Fukumura D, Leunig M, Berk D, Torchilin V . Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 1995; 55(17):3752-6. View

17.

Nag O, Awasthi V . Surface engineering of liposomes for stealth behavior. Pharmaceutics. 2013; 5(4):542-69. PMC: 3873679. DOI: 10.3390/pharmaceutics5040542. View

18.

Hobbs S, Monsky W, Yuan F, ROBERTS W, Griffith L, Torchilin V . Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A. 1998; 95(8):4607-12. PMC: 22537. DOI: 10.1073/pnas.95.8.4607. View

19.

Stylianopoulos T . EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumors. Ther Deliv. 2013; 4(4):421-3. DOI: 10.4155/tde.13.8. View

20.

Fernandez-Sanchez M, Barbier S, Whitehead J, Bealle G, Michel A, Latorre-Ossa H . Mechanical induction of the tumorigenic β-catenin pathway by tumour growth pressure. Nature. 2015; 523(7558):92-5. DOI: 10.1038/nature14329. View